• For Researchers

Hacking cancer cell metabolism

Restricting cancer cells of specific amino acids can slow tumour growth and sharpen the effects of chemotherapy and radiotherapy – now, startup Faeth Therapeutics is creating precision diets which can enhance cancer treatments. Restricting cancer cells of specific amino acids can slow tumour growth and sharpen the effects of chemotherapy and radiotherapy – now, startup Faeth Therapeutics is creating precision diets which can enhance cancer treatments.

30 January 2023

• For Researchers

Time to get stratified

As genetic screening becomes routine for cancer detection and treatment, we need to ensure this can be delivered at scale and quickly within a national health system. As genetic screening becomes routine for cancer detection and treatment, we need to ensure this can be delivered at scale and quickly within a national health system.

10 January 2023

• For Researchers

The power of partnership – the unique alliance taking on brain cancer

The Antibody Alliance Laboratory – a collaboration between Cancer Research UK and AstraZeneca – combines academic rigour with agile bioengineering to push forward antibody discovery projects... The Antibody Alliance Laboratory – a collaboration between Cancer Research UK and AstraZeneca – combines academic rigour with agile bioengineering to push forward antibody discovery projects...

15 December 2022

• For Researchers

Thinking outside the chromosome – how ecDNA is challenging conventional thinking

What is extrachromosomal DNA? How have we come to think of its role in cancer? And what has all this got to do with a flagship lung cancer study? What is extrachromosomal DNA? How have we come to think of its role in cancer? And what has all this got to do with a flagship lung cancer study?

11 November 2022

• Charity News

Cancer Research UK honours Her Majesty The Queen, the charity’s Patron

8 September 2022

• For Researchers

A cut above: Making drug discovery more efficient using CRISPR

CRISPR-Cas9 is a world-renowned genome editing tool, but much of the hype has been focused on direct clinical applications. However, there is clear potential for utilising the system in functional genomic screens to develop new cancer medicines... CRISPR-Cas9 is a world-renowned genome editing tool, but much of the hype has been focused on direct clinical applications. However, there is clear potential for utilising the system in functional genomic screens to develop new cancer medicines...

16 August 2022

• Charity News

2021/22 in review: Charity looks to the future with ambitious new strategy

21 July 2022

• Charity News

Pharmacy services are an untapped resource in tackling nation’s major health conditions, new survey reveals

12 July 2022

• For Researchers

Joining the dots: How our new research data strategy will unlock the power of big data

To capitalise on the reams of data produced by cancer researchers we must have a joined up approach - here's how our new strategy will help To capitalise on the reams of data produced by cancer researchers we must have a joined up approach - here's how our new strategy will help

7 July 2022